BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7514724)

  • 1. Mutation studies with dimethyl nitrosamine in young and old lac I transgenic mice.
    Tinwell H; Lefevre PA; Ashby J
    Mutat Res; 1994 Jun; 307(2):501-8. PubMed ID: 7514724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of shuttle vectors for mutation analysis in transgenic mice and rats.
    Dycaico MJ; Provost GS; Kretz PL; Ransom SL; Moores JC; Short JM
    Mutat Res; 1994 Jun; 307(2):461-78. PubMed ID: 7514720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experiences and future directions for transgenic mouse mutation assays.
    Suzuki T; Hayashi M; Sofuni T
    Mutat Res; 1994 Jun; 307(2):489-94. PubMed ID: 7514722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity.
    Suzuki T; Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T
    Mutat Res; 1998 Jan; 412(2):161-6. PubMed ID: 9539970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
    Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T
    Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific induction of mutations by streptozotocin in vivo.
    Schmezer P; Eckert C; Liegibel UM
    Mutat Res; 1994 Jun; 307(2):495-9. PubMed ID: 7514723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of the Muta mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses.
    Tinwell H; Lefevre PA; Ashby J
    Mutat Res; 1994 May; 307(1):169-73. PubMed ID: 7513794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
    Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sources of variability in data from a lacI transgenic mouse mutation assay.
    Piegorsch WW; Lockhart AM; Margolin BH; Tindall KR; Gorelick NJ; Short JM; Carr GJ; Thompson ED; Shelby MD
    Environ Mol Mutagen; 1994; 23(1):17-31. PubMed ID: 8125080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice.
    Butterworth BE; Templin MV; Constan AA; Sprankle CS; Wong BA; Pluta LJ; Everitt JI; Recio L
    Environ Mol Mutagen; 1998; 31(3):248-56. PubMed ID: 9585263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice as a model to study gene mutations: application as a short-term mutagenicity assay.
    Gossen JA; Vijg J
    Prog Clin Biol Res; 1990; 340A():347-54. PubMed ID: 2388919
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of lacI and lacZ transgenic mouse mutation assays: an EU-sponsored interlaboratory study.
    Tinwell H; Liegibel U; Krebs O; Schmezer P; Favor J; Ashby J
    Mutat Res; 1995 Oct; 335(2):185-90. PubMed ID: 7477049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice.
    Winegar RA; Lutze LH; Hamer JD; O'Loughlin KG; Mirsalis JC
    Mutat Res; 1994 Jun; 307(2):479-87. PubMed ID: 7514721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of hepatic mutations in lacI transgenic mice.
    Mirsalis JC; Provost GS; Matthews CD; Hamner RT; Schindler JE; O'Loughlin KG; MacGregor JT; Short JM
    Mutagenesis; 1993 May; 8(3):265-71. PubMed ID: 8332090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone.
    Autrup H; Jørgensen EC; Jensen O
    Mutagenesis; 1996 Jan; 11(1):69-73. PubMed ID: 8671718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
    Bielas JH
    Mutat Res; 2002 Jul; 518(2):107-12. PubMed ID: 12113761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombination-based transgenic mouse system for genotoxicity testing.
    Murti JR; Schimenti KJ; Schimenti JC
    Mutat Res; 1994 Jun; 307(2):583-95. PubMed ID: 7514731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LacZ transgenic mouse models: their application in genetic toxicology.
    Gossen JA; de Leeuw WJ; Vijg J
    Mutat Res; 1994 Jun; 307(2):451-9. PubMed ID: 7514719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzo[a]pyrene site of contact mutagenicity in skin of Muta Mouse.
    Dean SW; Coates A; Brooks TM; Burlinson B
    Mutagenesis; 1998 Sep; 13(5):515-8. PubMed ID: 9800197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.